duloxetine hydrochloride has been researched along with vortioxetine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 24 (80.00) | 24.3611 |
| 2020's | 6 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, DS; Dragheim, M; Loft, H | 1 |
| Hansen, T; Katona, C; Olsen, CK | 1 |
| Chen, Y; Jacobsen, PL; Mahableshwarkar, AR | 1 |
| Alam, MY; Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Serenko, M | 1 |
| Boulenger, JP; Loft, H; Olsen, CK | 1 |
| Budac, D; du Jardin, KG; Jensen, JB; Pehrson, AL; Sanchez, C; Smagin, G; Song, D | 1 |
| Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Simon, JS | 1 |
| Leiser, SC; Pehrson, AL; Robichaud, PJ; Sanchez, C | 1 |
| Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
| Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Serenko, M; Trivedi, MH | 1 |
| Chen, Y; Jacobson, W; Keefe, RS; Mahableshwarkar, AR; Zajecka, J | 1 |
| Papakostas, GI | 1 |
| Lee, Y; McIntyre, RS | 1 |
| Chen, F; Sánchez, C; Waller, JA | 1 |
| Baldwin, DS; Chrones, L; Florea, I; Nielsen, R; Nomikos, GG; Palo, W; Reines, E | 1 |
| Li, G; Ma, D; Wang, X | 1 |
| Andreasen, JT; Haubro, K; Pickering, DS; Refsgaard, LK; Robinson, ES; Stuart, SA | 1 |
| Gulinello, M; Li, Y; Sanchez, C | 1 |
| Fuller, RR; Hughes, S; Lacasse, J; Spaulding-Givens, J | 1 |
| Barbui, C; Breilmann, J; Guaiana, G; Koesters, M; Ostuzzi, G | 1 |
| Bundgaard, C; Hamilton, C; Ma, Z; Mørk, A; Pehrson, AL; Pérez, PD; Sánchez, C; Zhang, N | 1 |
| Christensen, MC; Munro, V | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Christensen, MC; Loft, H; McIntyre, RS | 1 |
| Djordjevic, JD; Jasnic, NI; Micov, AM; Pecikoza, UB; Stepanović-Petrović, RM; Todorović, MB; Tomić, MA; Vuković, MJ | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A | 1 |
| Alcántara Montero, A; Pacheco de Vasconcelos, SR | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Jovanović, A; Kotur-Stevuljević, J; Labudović-Borović, M; Micov, A; Nastić, K; Pecikoza, U; Stepanović-Petrović, R; Tomić, M | 1 |
9 review(s) available for duloxetine hydrochloride and vortioxetine
| Article | Year |
|---|---|
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Antidepressants and their effect on cognition in major depressive disorder.
Topics: Adult; Citalopram; Cognition Disorders; Depressive Disorder, Major; Duloxetine Hydrochloride; Executive Function; Humans; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Vortioxetine | 2015 |
Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
Topics: Antidepressive Agents; Cognition; Cognition Disorders; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Learning; Mental Recall; Piperazines; Recovery of Function; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Vortioxetine | 2016 |
Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.
Topics: Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Piperazines; Randomized Controlled Trials as Topic; Sulfides; Treatment Outcome; Vortioxetine | 2016 |
Vortioxetine for depression in adults.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Patient Dropouts; Piperazines; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Venlafaxine Hydrochloride; Vortioxetine | 2017 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Role of vortioxetine in the treatment of neuropathic pain.
Topics: Antidepressive Agents; Chronic Pain; Duloxetine Hydrochloride; Humans; Neuralgia; Vortioxetine | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
10 trial(s) available for duloxetine hydrochloride and vortioxetine
| Article | Year |
|---|---|
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD).
Topics: Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Logistic Models; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Reference Values; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine | 2012 |
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Sulfides; Thiophenes; Vortioxetine | 2012 |
A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Placebos; Sexual Dysfunction, Physiological; Suicidal Ideation; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine | 2013 |
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Suicidal Ideation; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Weight Gain; Young Adult | 2014 |
Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Headache; Humans; Internationality; Male; Middle Aged; Nausea; Piperazines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Young Adult | 2014 |
A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Young Adult | 2014 |
A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Electrocardiography; Fatigue; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Suicidal Ideation; Sulfides; Vortioxetine; Young Adult | 2015 |
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Cognition Disorders; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Sulfides; Surveys and Questionnaires; Treatment Outcome; Vortioxetine; Young Adult | 2015 |
Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cost-Benefit Analysis; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Self Report; Vortioxetine; Young Adult | 2018 |
Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
Topics: Adult; Aged; Cognition; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Outpatients; Psychometrics; Psychotherapy; Self Report; Surveys and Questionnaires; Vortioxetine; Young Adult | 2018 |
11 other study(ies) available for duloxetine hydrochloride and vortioxetine
| Article | Year |
|---|---|
Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Exploratory Behavior; Female; Hippocampus; Maze Learning; Memory Disorders; Phenylalanine; Piperazines; Protein Binding; Rats; Rats, Long-Evans; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Thiophenes; Vortioxetine | 2014 |
Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
Topics: Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Electroencephalography; Frontal Lobe; Male; Piperazines; Rats, Sprague-Dawley; Receptors, Serotonin; RNA-Binding Proteins; Sulfides; Thiophenes; Vortioxetine; Wakefulness | 2014 |
Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
Topics: Animals; Antidepressive Agents; Cells, Cultured; Dendritic Spines; Duloxetine Hydrochloride; Fluoxetine; Hippocampus; Ketamine; Piperazines; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Synapses; Vortioxetine | 2016 |
The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.
Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sulfides; Venlafaxine Hydrochloride; Vortioxetine; Young Adult | 2016 |
Effects of sertraline, duloxetine, vortioxetine, and idazoxan in the rat affective bias test.
Topics: Adrenergic alpha-2 Receptor Antagonists; Affect; Animals; Antidepressive Agents; Behavior, Animal; Duloxetine Hydrochloride; Idazoxan; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Vortioxetine | 2016 |
Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.
Topics: Aging; Animals; Antidepressive Agents; Cognition; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Fluoxetine; Memory; Mice, Inbred C57BL; Piperazines; Psychotropic Drugs; Random Allocation; Space Perception; Sulfides; Vilazodone Hydrochloride; Visual Perception; Vortioxetine | 2017 |
Adverse effects and treatment satisfaction among online users of four antidepressants.
Topics: Affective Symptoms; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Humans; Internet; Mental Disorders; Patient Satisfaction; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2017 |
Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
Topics: Animals; Antidepressive Agents; Brain; Duloxetine Hydrochloride; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neural Pathways; Oxygen; Piperazines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Rest; Sulfides; Vortioxetine; Wakefulness | 2018 |
Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy.
Topics: Animals; Antidepressive Agents; Antineoplastic Agents; Behavior, Animal; Brain Stem; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxaliplatin; Pain Measurement; Peripheral Nervous System Diseases; Serotonin; Swimming; Vortioxetine | 2020 |
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
The antidepressant drugs vortioxetine and duloxetine differentially and sex-dependently affect animal well-being, cognitive performance, cardiac redox status and histology in a model of osteoarthritis.
Topics: Animals; Antidepressive Agents; Cognition; Duloxetine Hydrochloride; Female; Hyperalgesia; Hypersensitivity; Myocytes, Cardiac; Osteoarthritis; Rats; Vortioxetine | 2023 |